Disease

Disease name: COVID-19

ICD-10 Disease Code: Z20.822 Contact with and (suspected) exposure to COVID-19

ICD-10 Disease Group: Z20- Contact with and (suspected) exposure to communicable diseases

General description:

Coronavirus disease (COVID-19) is a disease caused by infection with the SARS-CoV-2 virus. The virus officially emerged in China in 2019 and spread quickly to the rest of the world. After the initial wave of COVID-19, several variants have emerged all carrying unique traits brought on by mutations in the viral spike proteins expressed on the surface of the virus particle. The disease occurs along a spectrum of severity depending on several factors including pre-existing diseases, with variable outcomes. 

Mutations:

Not applicable. COVID-19 is an infectious disease and not a genetic disorder.

Disease frequency:

As of january 2022, 325 million people have been infected with COVID-19 globally

Symptoms:

The symptoms of COVID-19 vary a lot, from regular influenza-like symptoms such as coughing, fever, runny nose and headaches, to potentially life-threatening symptoms such as blood clots and loss of lung functionality. COVID-19 is also associated with long-term complete loss or alteration of taste and smell long after recovery from the infection.

Post-COVID symptoms also include effects on several vital organs such as the heart, lungs and kidneys. Autoimmune inflammation is also noted several months in some individuals who have recovered from COVID-19.

 

Treatment:

Several treatments have been approved by the U.S. Food and Drug administraton (FDA) for patients suffering from COVID-19 under different circumstances.

Antiviral drug Veklury (remdesivir) has been approved for the treatment of patients who are hospitalised for their symptoms. Drugs used in the treatment of COVID-19 treatments have occasionally been approved by the FDA through the emergency use authorisation (EUA). An example of an EUA-approved drug for the treatment and prevention of COVID-19 is the use of monoclonal antibody treatments in patients particularly susceptible to severe symptoms after infection.

Additionally, several different types of vaccines have been developed against COVID-19. Moderna and Pfizer in collaboration with BioNTech have all developed vaccines based on the new mRNA vaccine technology, where mRNA coding for the various regions of the viral spike protein is injected into the body and the body then naturally develops antibodies to fight the synthetic antigens.

Sources:

Tags

HashtagCOVID-19

close
Search CRISPR Medicine